Close Menu
  • Home
  • News & Updates
  • Startup Stories
  • Funding News
  • CEO Story
  • Interviews
  • Magazine
Facebook X (Twitter) Instagram
StartUp InsiderStartUp Insider
  • Home
  • News & Updates
  • Startup Stories
  • Funding News
  • CEO Story
  • Interviews
  • Magazine
StartUp InsiderStartUp Insider
Home - News & Updates - PharmEasy Plans INR 2,400 Cr Rights Issue at Steep Discount to Settle Debt
News & Updates

PharmEasy Plans INR 2,400 Cr Rights Issue at Steep Discount to Settle Debt

StartUp Insider DeskBy StartUp Insider Desk05/07/2023No Comments2 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
PharmEasy Plans INR 2,400 Cr Rights Issue at Steep Discount to Settle Debt@startupinsider.in
Share
Facebook Twitter LinkedIn Pinterest Email

Amid rising financial pressure, healthtech startup PharmEasy is planning to raise INR 2,400 Cr through a rights issue at a deeply discounted rate, marking a significant step in its debt repayment strategy [1]. This comes amidst a backdrop of a tightening financial environment for healthcare providers due to surging drug prices and looming policy changes [2].

The rights issue, expected to be led by existing shareholders TPG and Temasek, will occur at a staggering 90% discount. This move is projected to bring down PharmEasy’s valuation to a range of $500 Mn-$600 Mn, a drastic tumble from its previous valuation of $5.6 Bn in 2021. Ranjan Pai of Manipal Group is also expected to join the board, adding strategic depth and experience to the management [1].

This maneuver comes as PharmEasy looks to resolve its debt obligations to Goldman Sachs. The sizeable debt has been a significant weight on the startup’s financial health and its ability to function optimally in the competitive healthtech landscape. The forthcoming rights issue offers an opportunity for the firm to reset its financial position, alleviate its debt burden, and pivot its strategic focus towards operational growth and expansion.

Read more: GIVA, the D2C Jewellery Brand, Secures INR 270 Cr Investment from Premji Invest

PharmEasy’s plan arrives amidst a challenging time for the healthtech industry. Healthcare providers are grappling with rising drug costs and the potential for policy shifts, like the proposed changes to the 340B program [2]. These challenges highlight the importance of fiscal prudence and strategic financial management in maintaining operational viability and resilience.

Notably, the rising use of copay coupons by pharmaceutical manufacturers, which helps patients with out-of-pocket costs but escalates overall healthcare spending, is causing further tension in the sector [3]. Such industry dynamics underscore the necessity of robust financial strategies like the one PharmEasy is employing.

In conclusion, PharmEasy’s rights issue move could serve as a critical case study for other startups grappling with debt in the increasingly challenging healthcare landscape. It further highlights the significance of strategic financial planning and decision-making for survival and growth in the healthtech sector. As the story unfolds, industry stakeholders will be keenly observing the impact of this rights issue on PharmEasy’s journey.

#DebtRepayment #GoldmanSachs #HealthTech #ManipalGroup #PharmEasy #RanjanPai #RightsIssue #Temasek startup TPG
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
StartUp Insider Desk

Startup Insider is a prominent news website which deals with startup news, stories, interview tips, gives the latest update about events and conferences.

Related Posts

Tax Benefits For Entrepreneurs In India

20/03/2024

10 Common Credit Card Mistakes and How to Avoid Them?

16/02/2024

The Ultimate Guide to Turning Your Startup Into a Big Success

16/02/2024

How to manage your debts effectively with a Personal Loan?

17/01/2024
What's Hot

A Fair Car Accident Settlement Includes These 6 Losses

29/04/2025

NUOS: Innovating Smart Home Automation with Touch and Intelligence

16/04/2025

Outsourcing on a Budget: How Small Businesses Can Negotiate Cost-Effective Contracts

15/04/2025
Follow Us on Google News


Tech magazine

Subscribe to Updates

Get the latest Business news from StartUp Insider about startup stories, funding news, CEO stories.

Welcome to StartupInsider, your go-to source for the latest news, insights, and analysis on startups and businesses in india. We are dedicated to providing you with accurate and up-to-date information that can help you navigate the ever-evolving landscape of entrepreneurship.

Content Us : media@startupinsider.in

Facebook X (Twitter) Instagram Pinterest YouTube Tumblr LinkedIn
Editors Picks

Mangal Paper Pvt. Ltd. (Mangal Group) Sets Industry Benchmark with Exceptional Sales Achievement

10/05/2024

Fueling the Future: Chennai based AI EdTech Startup KambGeeks Raises Pre-Seed Funding

30/04/2024

VedaOils – Emerging Brand In The Essential Oils Industries

04/04/2024

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

© 2025 StartUp Insider.
  • Home
  • About Us
  • Terms of Use
  • Privacy
  • Contact Us
  • Disclaimer

Type above and press Enter to search. Press Esc to cancel.